Bridges Investment Management Inc. Sells 100 Shares of The Clorox Company (NYSE:CLX)

Bridges Investment Management Inc. cut its stake in shares of The Clorox Company (NYSE:CLX) by 1.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,772 shares of the company’s stock after selling 100 shares during the period. Bridges Investment Management Inc.’s holdings in Clorox were worth $1,425,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Integral Investment Advisors Inc. grew its position in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after buying an additional 67 shares during the period. HCR Wealth Advisors boosted its stake in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after acquiring an additional 68 shares during the last quarter. Empower Advisory Group LLC grew its holdings in Clorox by 4.5% during the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after purchasing an additional 78 shares during the period. Aviance Capital Partners LLC grew its holdings in Clorox by 2.7% during the third quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after purchasing an additional 80 shares during the period. Finally, Lindbrook Capital LLC increased its stake in Clorox by 9.9% in the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after purchasing an additional 88 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX opened at $156.52 on Monday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The stock has a market capitalization of $19.28 billion, a P/E ratio of 42.76, a P/E/G ratio of 2.62 and a beta of 0.42. The company has a 50 day moving average of $156.88 and a 200-day moving average of $160.37.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company earned $2.16 earnings per share. As a group, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.12%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Barclays boosted their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Clorox has an average rating of “Hold” and a consensus price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.